BioSpace News Archive

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for ET140202 ARTEMIS™ T-cell therapy in AFP-positive patients with advanced hepatocellular carcinoma (HCC), the most common type of liver cancer.

Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) (“Company”), the world’s leading temperature-controlled logistics company dedicated to the life sciences industry, today will celebrate the official opening of its most recent Global Logistics Center, based in Amsterdam, The Netherlands.

“We are urging a plumber, electrician, mechanic, machinist, welder, insulator or any other type of skilled trades worker with mesothelioma or asbestos exposure lung cancer in Ohio or their family to call us anytime at 800-714-0303 so we can explain how incredibly vital it is to have a team of the nation’s most skilled mesothelioma lawyers working on their compensation claim.

Facing youth e-cigarette epidemic, American Lung Association calls for federal government, states to put in place proven tobacco control policies to protect kids, save lives

Genentech, a member of the Roche Group, announced the decision to discontinue CREAD 1 and CREAD 2 Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with early sporadic Alzheimer’s disease.

Executive Chairman Tim Day to Present at Photonics West Marketplace Seminar

Peroxfarma, the company behind the Epaplus line of nutritional supplements, wants to give everyone an “extra dose” of health.

BioInvent is currently investigating this combination in Phase I/IIa study

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that Bill Peck, Ph.D., chief technology officer, participated in the Future Health Threats Initiative 2019, a conference designed to encourage public-private cooperation to strengthen health security in Africa.

Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.